Omeros | Passivo Circulante



Current Liabilities Alterar Data
Adma Biologics USD 55.54M 10.65M 2024-12
Alnylam Pharmaceuticals USD 1.08B 110.65M 2025-03
BioMarin Pharmaceutical USD 628.21M 21.22M 2025-03
Cytokinetics USD 159.73M 19.95M 2025-03
Dynavax Technologies USD 68.38M 10.26M 2025-03
Gilead Sciences USD 12B 279M 2024-12
Insmed USD 239.23M 58.29M 2025-03
Knight Therapeutics CAD 118.15M 12.32M 2024-09
MacroGenics USD 55.53M 3.78M 2024-12
Pacira USD 314.73M 4.81M 2025-03
Pfizer USD 36.45B 6.54B 2025-03
Sarepta Therapeutics USD 605.59M 126.1M 2025-03
United Therapeutics USD 721.5M 16.6M 2025-03
Vertex Pharmaceuticals USD 3.56B 408.5M 2024-12



Omeros Passivo Circulante - Valores atuais, dados históricos, previsões, estatísticas, gráficos e calendário econômico - Jul 2025.